KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 170 filers reported holding KARYOPHARM THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.86 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $1,185,630 | +258.3% | 662,363 | +580.5% | 0.00% | – |
Q4 2022 | $330,943 | +308.6% | 97,336 | +559.1% | 0.00% | – |
Q3 2022 | $81,000 | -91.4% | 14,768 | -92.9% | 0.00% | – |
Q2 2022 | $941,000 | -81.8% | 208,597 | -70.3% | 0.00% | -100.0% |
Q1 2022 | $5,169,000 | +123.2% | 701,443 | +94.8% | 0.00% | – |
Q4 2021 | $2,316,000 | +442.4% | 360,143 | +391.1% | 0.00% | – |
Q3 2021 | $427,000 | -35.4% | 73,328 | +14.5% | 0.00% | – |
Q2 2021 | $661,000 | -46.4% | 64,042 | -45.4% | 0.00% | – |
Q1 2021 | $1,233,000 | -59.4% | 117,225 | -40.3% | 0.00% | -100.0% |
Q4 2020 | $3,039,000 | +50.5% | 196,358 | +42.0% | 0.00% | +100.0% |
Q3 2020 | $2,019,000 | -63.0% | 138,325 | -52.0% | 0.00% | -80.0% |
Q2 2020 | $5,457,000 | +111.7% | 288,119 | +114.7% | 0.01% | +66.7% |
Q1 2020 | $2,578,000 | +801.4% | 134,200 | +798.4% | 0.00% | – |
Q4 2019 | $286,000 | +38.8% | 14,937 | -30.3% | 0.00% | – |
Q3 2019 | $206,000 | -68.7% | 21,423 | +51.6% | 0.00% | -100.0% |
Q2 2014 | $658,000 | – | 14,132 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Delphi Management Partners VIII, L.L.C. | 2,263,006 | $35,031,000 | 23.03% |
Palo Alto Investors LP | 5,267,652 | $81,543,000 | 4.28% |
Fairmount Funds Management LLC | 702,351 | $10,872,000 | 3.89% |
Birchview Capital, LP | 188,000 | $2,910,000 | 1.68% |
Mesirow Financial Investment Management, Inc. | 22,303 | $345,250,000 | 1.09% |
EMERALD ADVISERS, LLC | 1,822,781 | $28,217,000 | 0.94% |
EMERALD MUTUAL FUND ADVISERS TRUST | 1,661,236 | $25,716,000 | 0.90% |
RICE HALL JAMES & ASSOCIATES, LLC | 1,552,504 | $24,033,000 | 0.85% |
Altium Capital Management LP | 133,951 | $2,074,000 | 0.77% |
Hood River Capital Management LLC | 931,754 | $14,424,000 | 0.48% |